Safety of mirogabalin and pregabalin in Japanese patients with neuropathic pain: a retrospective cohort study.
Rie NakajimaNobuhiro OobaMiwako KameiHajime HashibaChoichiro MiyazakiPublished in: Expert opinion on drug safety (2023)
No new serious safety concerns were found for mirogabalin and pregabalin use in patients with neuropathic pain, although the HR of some events indicated increased risk among mirogabalin users. However, further studies are needed as estimates for events occurring in small numbers with wide confidence intervals.